Back to Search
Start Over
Idarucizumab administration for reversing dabigatran effect in an acute kidney injured patient with bleeding.
- Source :
-
Thrombosis and haemostasis [Thromb Haemost] 2017 Jan 05; Vol. 117 (1), pp. 196-197. Date of Electronic Publication: 2016 Oct 13. - Publication Year :
- 2017
- Subjects :
- Acute Kidney Injury diagnosis
Acute Kidney Injury etiology
Acute Kidney Injury therapy
Aged
Antibodies, Monoclonal, Humanized pharmacokinetics
Antidotes pharmacokinetics
Atrial Fibrillation blood
Atrial Fibrillation diagnosis
Dabigatran antagonists & inhibitors
Hemorrhage blood
Hemorrhage chemically induced
Hemorrhage diagnosis
Humans
Male
Severity of Illness Index
Treatment Outcome
Acute Kidney Injury physiopathology
Antibodies, Monoclonal, Humanized administration & dosage
Antidotes administration & dosage
Antithrombins adverse effects
Atrial Fibrillation drug therapy
Dabigatran adverse effects
Hemorrhage drug therapy
Hemostasis drug effects
Subjects
Details
- Language :
- English
- ISSN :
- 2567-689X
- Volume :
- 117
- Issue :
- 1
- Database :
- MEDLINE
- Journal :
- Thrombosis and haemostasis
- Publication Type :
- Report
- Accession number :
- 27734073
- Full Text :
- https://doi.org/10.1160/TH16-06-0445